Stay updated on Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added access to the Study Protocol and Statistical Analysis Plan PDFs in the Study Documents section, along with associated metadata such as file size and upload dates.
    Difference
    72%
    Check dated 2026-08-12T02:51:49.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page now shows an updated Revision tag (v3.6.4), replacing the prior revision (v3.6.3) in the page metadata.
    Difference
    0.0%
    Check dated 2026-07-21T13:40:40.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.6.3' was added, replacing the previous 'Revision: v3.6.0' tag to indicate an updated patch version on the page.
    Difference
    0.0%
    Check dated 2026-06-30T01:24:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    New guidance sections were added to help readers read the study record and understand how to join. The recruitment status was updated to No longer looking for participants, indicating enrollment has closed.
    Difference
    0.3%
    Check dated 2026-06-15T19:12:54.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Revision tag for the study documents updated from v3.5.4 to v3.5.5. This reflects an updated version of the documents referenced on the page.
    Difference
    0.0%
    Check dated 2026-06-08T17:09:28.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Publication details for a PubMed-listed article related to the study were added under Publications, including authors, title, journal, year, and DOI. A note explains that some entries are auto-filled from PubMed and may not be exclusively about the study.
    Difference
    0.2%
    Check dated 2026-05-25T08:53:45.000Z thumbnail image

Stay in the know with updates to Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab Combo in FRα+ Ovarian Cancer Clinical Trial page.